Effect of in-hospital pulmonary rehabilitation in COVID-19 pneumonia patients

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20221227003

Enrollment

Registered

2022-12-27

Start date

2021-12-27

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 pneumonia COVID-19, SAR-CoV2, pneumonia, pulmonary rehabiltation

Interventions

In-hospital pulmonary rehabilitation consists with positioning therpay, positive expiratory pressure, lung recruitment, airway clearance and early mobilization under supervised by well-trained physiot

Experimental Procedure/Surgery

pulmonary rehabilitation

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. The patients with COVID-19 pneumonia confirmed by radiologic study 2. hypoxemia or non-hypoxemia

Exclusion criteria

Exclusion criteria: 1. Requirement of oxygen therapy higher than FiO2 0.4 2. Unstable hemodynamics or uncontrolled arrhythmia 3. pneumothorax or pneumomediastinum 4. thromboembolism or deep vein thrombosis 5. cognitive dysfunction 6. bleeding tendency

Design outcomes

Primary

Measure	Time frame
Dyspnea score 1 month Transitional dyspnea index	—

Secondary

Measure	Time frame
Quality of life 1 month SGRQ	—

Countries

Thailand

Contacts

Public ContactWorawat Chumpangern

Khon Kaen University

worawat@kku.ac.th0885638864

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026